File Download

There are no files associated with this item.

  • Find it @ UNIST can give you direct access to the published full text of this article. (UNISTARs only)
Related Researcher

고명곤

Ko, Myunggon
Cancer Epigenetics Lab.
Read More

Views & Downloads

Detailed Information

Cited time in webofscience Cited time in scopus
Metadata Downloads

Full metadata record

DC Field Value Language
dc.citation.endPage 456 -
dc.citation.number 4 -
dc.citation.startPage 445 -
dc.citation.title ONCOGENE -
dc.citation.volume 30 -
dc.contributor.author Ahn, Jungeun -
dc.contributor.author Ko, Myung Gon -
dc.contributor.author Lee, Changjin -
dc.contributor.author Kim, Jieun -
dc.contributor.author Yoon, Hana -
dc.contributor.author Seong, Rho H -
dc.date.accessioned 2023-12-22T06:37:03Z -
dc.date.available 2023-12-22T06:37:03Z -
dc.date.created 2015-07-24 -
dc.date.issued 2011-01 -
dc.description.abstract Some subunits of the SWI/SNF complex function as tumor suppressors. However, underlying mechanisms are still incompletely defined. Here, we show that Srg3, a mouse homolog of BAF155 that function as a core subunit of this complex, suppresses tumorigenesis in vivo. DNA damage signals promoted Srg3 degradation by inducing p53. Deficiency of Srg3 promoted G1 cell-cycle arrest, but antagonized apoptotic response to DNA damage by robustly inducing p53 and p21 proteins. Srg3 heterozygous mice were prone to sarcoma formation, which was further enhanced by haploinsufficiency of p53. These tumors highly expressed p53 and p21 but lacked Srg3 expression. Our results establish a novel function of Srg3 in tumor suppression and provide insights into genetic pathways dictating tumor suppression by the SWI/SNF complex. -
dc.identifier.bibliographicCitation ONCOGENE, v.30, no.4, pp.445 - 456 -
dc.identifier.doi 10.1038/onc.2010.424 -
dc.identifier.issn 0950-9232 -
dc.identifier.scopusid 2-s2.0-79251622203 -
dc.identifier.uri https://scholarworks.unist.ac.kr/handle/201301/12636 -
dc.identifier.wosid 000286621600007 -
dc.language 영어 -
dc.publisher NATURE PUBLISHING GROUP -
dc.title Srg3 is a novel p53 target and acts as a tumor suppressor by modulating p21WAF1/CIP1 expression -
dc.type Article -
dc.description.journalRegisteredClass scie -
dc.description.journalRegisteredClass scopus -

qrcode

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.